![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Identification and Characterization of PPI-461, a Potent and Selective HCV NS5A Inhibitor with Activity Against all HCV Genotypes
|
|
|
Reported by Jules Levin
EASL Apr 14-18 2010 Vienna Austria
Richard Colonno, Ningwu Huang, Margaret Bencsik, Eric Peng, Anja Huq, Qi Huang, Min Zhong and Leping Li Presidio Pharmaceuticals, San Francisco, CA, USA
![](../images/041510/041510-10/image002.gif)
![](../images/041510/041510-10/image004.gif)
![](../images/041510/041510-10/image006.gif)
1Nettles et al. Poster 893, AASLD 2008
![](../images/041510/041510-10/image008.gif)
![](../images/041510/041510-10/image010.gif)
![](../images/041510/041510-10/image012.gif)
![](../images/041510/041510-10/image014.gif)
![](../images/041510/041510-10/image016.gif)
![](../images/041510/041510-10/image018.gif)
![](../images/041510/041510-10/image020.gif)
![](../images/041510/041510-10/image022.gif)
![](../images/041510/041510-10/image024.gif)
![](../images/041510/041510-10/image026.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|